Matches in Wikidata for { <http://www.wikidata.org/entity/Q65545732> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q65545732 description "clinical trial" @default.
- Q65545732 description "ensayu clínicu" @default.
- Q65545732 description "klinisch onderzoek" @default.
- Q65545732 description "клінічне випробування" @default.
- Q65545732 description "կլինիկական փորձարկում" @default.
- Q65545732 name "Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin" @default.
- Q65545732 name "Study to Monitor the Incidence of Pure Red Cell Aplasia" @default.
- Q65545732 type Item @default.
- Q65545732 label "Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin" @default.
- Q65545732 label "Study to Monitor the Incidence of Pure Red Cell Aplasia" @default.
- Q65545732 prefLabel "Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin" @default.
- Q65545732 prefLabel "Study to Monitor the Incidence of Pure Red Cell Aplasia" @default.
- Q65545732 P1132 Q65545732-ED9A59AB-3346-46EF-AB1A-1570919D7BDD @default.
- Q65545732 P1476 Q65545732-B4C88E3D-2D87-4C51-AF1C-E624BC2A282E @default.
- Q65545732 P2899 Q65545732-68E94A7B-BDF1-4EC5-8255-8031F4B59AA6 @default.
- Q65545732 P3098 Q65545732-54821B00-1908-47A5-A475-3A6FFFB1410B @default.
- Q65545732 P31 Q65545732-4666766B-C974-48AF-A279-D07B2767B775 @default.
- Q65545732 P4844 Q65545732-AF6E036C-0117-4E93-B7C4-2130C5E61338 @default.
- Q65545732 P580 Q65545732-B59C1692-0884-4EE7-B4D4-600AC587C6B7 @default.
- Q65545732 P582 Q65545732-7A83C140-D130-48EB-8D20-92E9A5E6924F @default.
- Q65545732 P8363 Q65545732-F9A194DA-308B-439C-AB01-2FD9F30D1C74 @default.
- Q65545732 P1132 "+4761" @default.
- Q65545732 P1476 "An Active Safety Surveillance Plan to Conduct Serologic Testing for Anti-erythropoietin Antibodies and Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) Among Patients Receiving Epoetin Alfa or Another Erythropoietin" @default.
- Q65545732 P2899 "+18" @default.
- Q65545732 P3098 "NCT00210951" @default.
- Q65545732 P31 Q30612 @default.
- Q65545732 P4844 Q5383794 @default.
- Q65545732 P580 "2003-05-01T00:00:00Z" @default.
- Q65545732 P582 "2005-07-01T00:00:00Z" @default.
- Q65545732 P8363 Q818574 @default.